BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

267 related articles for article (PubMed ID: 31975530)

  • 1. Severe achondroplasia due to two de novo variants in the transmembrane domain of FGFR3 on the same allele: A case report.
    Nagata T; Matsushita M; Mishima K; Kamiya Y; Kato K; Toyama M; Ogi T; Ishiguro N; Kitoh H
    Mol Genet Genomic Med; 2020 Mar; 8(3):e1148. PubMed ID: 31975530
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification and in silico characterization of p.G380R substitution in FGFR3, associated with achondroplasia in a non-consanguineous Pakistani family.
    Ajmal M; Mir A; Shoaib M; Malik SA; Nasir M
    Diagn Pathol; 2017 Jul; 12(1):47. PubMed ID: 28679403
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Severe complications in a child with achondroplasia and two FGFR3 mutations on the same allele.
    Rump P; Letteboer TG; Gille JJ; Torringa MJ; Baerts W; van Gestel JP; Verheij JB; van Essen AJ
    Am J Med Genet A; 2006 Feb; 140(3):284-90. PubMed ID: 16411219
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An improved tetra-primer PCR approach for the detection of the FGFR3 G380R mutation responsible for achondroplasia.
    Etlik O; Koksal V; Tugba Arican-Baris S; Baris I
    Mol Cell Probes; 2008 Apr; 22(2):71-5. PubMed ID: 17683901
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel phenotype of achondroplasia due to biallelic FGFR3 pathogenic variants.
    Chang IJ; Sun A; Bouchard ML; Kamps SE; Hale S; Done S; Goldberg MJ; Glass IA
    Am J Med Genet A; 2018 Jul; 176(7):1675-1679. PubMed ID: 30160829
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Knock-in human FGFR3 achondroplasia mutation as a mouse model for human skeletal dysplasia.
    Lee YC; Song IW; Pai YJ; Chen SD; Chen YT
    Sci Rep; 2017 Feb; 7():43220. PubMed ID: 28230213
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Suppression of severe achondroplasia with developmental delay and acanthosis nigricans by the p.Thr651Pro mutation.
    Manickam K; Donoghue DJ; Meyer AN; Snyder PJ; Prior TW
    Am J Med Genet A; 2014 Jan; 164A(1):243-50. PubMed ID: 24352917
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Clinical features and
    Zhang HQ; Tao DY; Zhang JJ; Niu HH; Luo JF; Cheng SQ
    Zhongguo Dang Dai Er Ke Za Zhi; 2022 Apr; 24(4):405-410. PubMed ID: 35527416
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Maternal administration of meclozine for the treatment of foramen magnum stenosis in transgenic mice with achondroplasia.
    Matsushita M; Mishima K; Esaki R; Ishiguro N; Ohno K; Kitoh H
    J Neurosurg Pediatr; 2017 Jan; 19(1):91-95. PubMed ID: 27767902
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel FGFR3 mutations creating cysteine residues in the extracellular domain of the receptor cause achondroplasia or severe forms of hypochondroplasia.
    Heuertz S; Le Merrer M; Zabel B; Wright M; Legeai-Mallet L; Cormier-Daire V; Gibbs L; Bonaventure J
    Eur J Hum Genet; 2006 Dec; 14(12):1240-7. PubMed ID: 16912704
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Achondroplasia in Turkey is defined by recurrent G380R mutation of the FGFR3 gene.
    Pehlivan S; Ozkinay F; Okutman O; Coğulu O; Ozcan A; Cankaya T; Ulgenalp A
    Turk J Pediatr; 2003; 45(2):99-101. PubMed ID: 12921294
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of the achondroplasia mutation on FGFR3 dimerization and FGFR3 structural response to fgf1 and fgf2: A quantitative FRET study in osmotically derived plasma membrane vesicles.
    Sarabipour S; Hristova K
    Biochim Biophys Acta; 2016 Jul; 1858(7 Pt A):1436-42. PubMed ID: 27040652
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Mutations in the Fibroblast Growth Factor Receptor 3 gene (FGFR3) in Chilean patients with idiopathic short stature, hypochondroplasia and achondroplasia].
    Mancilla EE; Poggi H; Repetto G; García C; Foradori A; Cattani A
    Rev Med Chil; 2003 Dec; 131(12):1405-10. PubMed ID: 15022403
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Typical achondroplasia secondary to a unique insertional variant of FGFR3 with in vitro demonstration of its effect on FGFR3 function.
    Meyer AN; Modaff P; Wang CG; Wohler E; Sobreira NL; Donoghue DJ; Pauli RM
    Am J Med Genet A; 2021 Mar; 185(3):798-805. PubMed ID: 33368972
    [TBL] [Abstract][Full Text] [Related]  

  • 15. p.Ser348Cys mutation in FGFR3 gene leads to "Mild ACH /Severe HCH" phenotype.
    Bengur FB; Ekmekci CG; Karaarslan E; Gunoz H; Alanay Y
    Eur J Med Genet; 2020 Feb; 63(2):103659. PubMed ID: 31048079
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mild achondroplasia/hypochondroplasia with acanthosis nigricans, normal development, and a p.Ser348Cys FGFR3 mutation.
    Couser NL; Pande CK; Turcott CM; Spector EB; Aylsworth AS; Powell CM
    Am J Med Genet A; 2017 Apr; 173(4):1097-1101. PubMed ID: 28181399
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Psychomotor Delay in a Child with
    Ergoren MC; Eren E; Manara E; Paolacci S; Tulay P; Sag SO; Bertelli M; Mocan G; Temel SG
    Glob Med Genet; 2021 Sep; 8(3):100-103. PubMed ID: 34430961
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of the G375C and G346E achondroplasia mutations on FGFR3 activation.
    He L; Serrano C; Niphadkar N; Shobnam N; Hristova K
    PLoS One; 2012; 7(4):e34808. PubMed ID: 22529939
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Delayed bone age due to a dual effect of FGFR3 mutation in Achondroplasia.
    Pannier S; Mugniery E; Jonquoy A; Benoist-Lasselin C; Odent T; Jais JP; Munnich A; Legeai-Mallet L
    Bone; 2010 Nov; 47(5):905-15. PubMed ID: 20673820
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Achondroplasia: from genotype to phenotype.
    Richette P; Bardin T; Stheneur C
    Joint Bone Spine; 2008 Mar; 75(2):125-30. PubMed ID: 17950653
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.